Boehringer Ingelheim, Dialysis Philippines Support Group, Kidney Transplant Association of the Philippines, and Philippine Alliance of Patient Organizations promote National Kidney Month with a public awareness event called It Starts With U: Get CheCKD. Chronic Kidney Disease (CKD) is a leading cause of death in the Philippines, with 2.3 million currently diagnosed and projections showing 1 in 10 developing the deadly disease. CKD often presents few symptoms during its early stages, and people only realize it when it has advanced.

To spread awareness about CKD, patient organizations and medical societies came together to celebrate National Kidney Month by helping Filipinos detect the early symptoms of CKD and educating them on prevention with the event, It Starts with U: Get CheCKD.

Dr. Rose Marie Rosete Liquete Executive Director National Kidney and Transplant Institute 2 Patient and Health Leaders Remind Us to Get CheCKD

During the event, Experts shared the prevalence and dangers of CKD and how Filipinos can adopt simple yet effective measures to protect themselves.

Dr. Maaliddin B. Biruar, a renowned nephrologist in the Philippines: “CKD is one of the most common chronic illnesses in the Philippines, and part of its danger is the difficulty in early detection since its symptoms don’t manifest until it’s too late. However, this condition can be easily mitigated by regular testing and adapting a few lifestyle changes.”

Boehringer Ingelheim also launched the ‘It Starts With You’ disease awareness website, an educational and informative public site for chronic kidney disease.

Dr. Greta Cortez Head of Human Pharma Boehringer Ingelheim Philippines Patient and Health Leaders Remind Us to Get CheCKD

Dr. Greta Cortez, Head of Medicine for Human Pharma, Boehringer Ingelheim Philippines: “Accessible tools and education are essential in combating CKD. With tools like this website, we can empower Filipinos with the knowledge and understanding to detect and manage CKD early. Early detection through accessible testing can significantly improve outcomes and enhance the quality of life for those affected by this silent but serious condition.”